News

23andMe to voluntarily delist from Nasdaq, deregister with SEC
Human genetics testing firm 23andMe announced Tuesday it will voluntarily delist from the Nasdaq and deregister with the U.S.
pharmaphorum1d
23andMe founder isn't giving up her bid to regain control
23andMe has said it wants to allow new bids by both parties with a deadline of 12th June, according to a Financial Times ...
Nasdaq5d
The Company Buying 23andMe Is a Pharmaceutical Giant. Here's How Investors Can Benefit From the Move.
On May 19, Regeneron Pharmaceuticals (NASDAQ: REGN) announced that it was the successful bidder for substantially all of 23andMe's assets, agreeing to pay $256 million for them. The deal is still ...
Nasdaq7d
23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
Nasdaq previously suspended the trading of 23andMe’s Class A common stock, $0.0001 par value per share (the “Common Stock”), at the opening of business on March 31, 2025 and notified the ...
23andMe to delist from Nasdaq, deregister with SEC
Me on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange ...
23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading ...